Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1161-1180 of 1,334 trials

A Phase 1 Drug-drug Interaction Study in Healthy Volunteers

NCT02227173

This is an open-label, single-sequence, drug-drug interaction study in healthy male and female subjects. There is no formal research hypothesis to be statistically tested. It is expected that coadministration of BMS-986020 with montelukast, flurbiprofen, and digoxin may increase the exposure of montelukast, flurbiprofen, and digoxin.

Drug-drug Interaction Study

Bristol-Myers Squibb20 participantsStarted Sep 2014

San Antonio, Texas, United States

COMPLETED< 1 mile

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

NCT01348061

This is an experimental medicine study to evaluate the kinetics of cerebrospinal fluid (CSF) biomarkers in subjects with Alzheimer's disease (AD) or progressive supranuclear palsy (PSP) compared to healthy controls using a heavy water (2H2O) labeling method. This study is exploring the time profile of appearance and disappearance of pulse deuterium-labeled cargo proteins in CSF of subjects with AD and/or PSP, which is different from healthy controls, due to deficits in fast axonal transport.

Alzheimer DiseaseProgressive Supranuclear Palsy

KineMed16 participantsStarted Jul 2011

Glendale, California, United States • Eatontown, New Jersey, United States • San Antonio, Texas, United States

COMPLETEDPHASE3< 1 mile

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

NCT00454740

To evaluate the efficacy of 5 and10mg solifenacin succinate in patients with urgency who have OAB syndrome (urgency, with or without urge incontinence, usually with frequency and nocturia) and wish to switch from tolterodine tartrate extended release to solifenacin succinate due to lack of sufficient improvement in urgency episodes

Urinary Bladder, Overactive

Astellas Pharma Inc441 participantsStarted Jun 2004

Anchorage, Alaska, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +101 more locations

A Phase 1 Drug-drug Interaction Study in Healthy Volunteers

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

Rheumatoid Arthritis Trials in Other Cities

Study of Silodosin to Facilitate Passage of Urinary Stones

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

RAMP Study: A Study Comparing Two Lumbar Fusion Procedures

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

EU/LA Pearl Index Study - Transdermal Contraceptive Patch

An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

Other Conditions in San Antonio